A Rare Cause of Hypertestosteronemia in a 68-Year-Old Patient: A Leydig Cell Tumor Due to a Somatic GNAS (Guanine Nucleotide-Binding Protein, Alpha-Stimulating Activity Polypeptide 1)-Activating Mutation

Institut National de la Santé et de la Recherche Médicale (INSERM) Unité 1016, Centre National de la Recherche Scientifique Unité Mixte de Recherche 8104, Department of Endocrinology, Metabolism and Cancer, Institut Cochin, Paris, France.
Journal of Andrology (Impact Factor: 2.47). 10/2011; 33(4):578-84. DOI: 10.2164/jandrol.111.013441
Source: PubMed


Leydig cell tumors of the testis are the most common type of non-germ cell testicular tumors. In adult patients, gynecomastia, oligozoospermia, erectile dysfunction, and other signs of feminization can be present, whereas testosterone levels are frequently in the normal range or slightly reduced. We describe a patient with a history of impaired sexual function, as well as progressive enlargement of the left testis, without gynecomastia. Hormonal evaluation demonstrated very high testosterone, estrogen, and pan-alpha-inhibin levels. Magnetic resonance imaging revealed the presence of left testicular hypertrophy without evidence of testicular mass. After left orchiectomy, histologic examination confirmed the diagnosis of Leydig cell tumor, and steroid hormone levels normalized. A heterozygous missense somatic gsp mutation (R201C) was found in tumoral tissue, whereas no mutation was found in the surrounding normal tissue or in leukocyte DNA. This case provides evidence that somatic activating gsp mutation in Leydig cells may result in tumor development, leading to overexpression of the inhibin alpha subunit and hyperactivity of the testosterone biosynthetic pathway.

Download full-text


Available from: Estelle Louiset, Nov 21, 2014
  • Source

    Full-text · Article · Oct 2012
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: The gene encoding the Gsα protein gene GNAS (Guanine Nucleotide binding protein, Alpha Stimulating) is located in one of the most complex locus of the human genome, the GNAS locus, on the long arm of chromosome 20 (20q13.32) (Gejman et al., 1991). The complexity of this locus does not lie only in the four alternative first exons splicing onto common exons 2 to 13, or the antisense transcript that resides in this locus, but this locus also presents an elaborated imprinting pattern. The genomic imprinting is an epigenetic process in which a specific imprint mark is erased in primordial germ cells and then reestablished during oogenesis or spermatogenesis, resulting in suppression of gene expression from one parental allele (Reik and Walter, 2001). This differential gene expression may take whole lifetime or just a limited developmental stage, and can be generalized to all tissues that express the gene or may be tissue dependent (Latham, 1995; Solter, 1998). In most cases, the methylation of the allele is the imprinting mark (addition of methyl groups on cytosine in the CpG dinucleotides), but other times, the imprinting mechanism remains unknown.
    Full-text · Dataset · Oct 2012
  • [Show abstract] [Hide abstract]
    ABSTRACT: Men with Kallmann syndrome (KS) and those with congenital isolated hypogonadotropic hypogonadism with normal olfaction share a chronic, usually profound deficit, in FSH and LH, the two pituitary gonadotropins. Many studies indicate that this gonadotropin deficiency is already present during fetal life, thus explaining the micropenis, cryptorchidism and marked testicular hypotrophy already present at birth. In addition, neonatal activation of gonadotropin secretion is compromised in boys with severe CHH/Kallmann, preventing the first phase of postnatal testicular activation. Finally, CHH is characterized by the persistence, in the vast majority of cases, of gonadotropin deficiency at the time of puberty and during adulthood. This prevents the normal pubertal testicular reactivation required for physiological sex steroid and testicular peptide production, and for spermatogenesis. CHH/KS thus represents a pathological paradigm that can help to unravel, in vivo, the role of each gonadotropin in human testicular exocrine and endocrine functions at different stages of development. Recombinant gonadotropins with pure LH or FSH activity have been used to stimulate Leydig's cells and Sertoli's cells, respectively, and thereby to clarify their paracrine interaction in vivo. The effects of these pharmacological probes can be assessed by measuring the changes they provoke in circulating testicular hormone concentrations. This review discusses the impact of chronic gonadotropin deficiency on the endocrine functions of the interstitial compartment, which contains testosterone-, estradiol- and INSL3-secreting Leydig's cells. It also examines the regulation of inhibin B and anti-Mullerian hormone (AMH) secretion in the seminiferous tubules, and the insights provided by studies of human testicular stimulation with recombinant gonadotropins, used either individually or in combination.
    No preview · Article · May 2014 · Annales d Endocrinologie
Show more